{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3014, 
        3028
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        3407, 
        3416
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5013, 
        5036
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2883, 
        2910
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        541, 
        570
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4936, 
        4971
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2821, 
        2847
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        3391, 
        3406
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3370, 
        3374
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3030, 
        3037
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3052, 
        3053
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3004, 
        3013
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3381, 
        3390
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3483, 
        3500
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1084007^CLIA|eMARCPlus|TN Cancer Registry|20170916000027||ORU^R01^ORU_R01|201709160000270001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-ES-012106^PathSys^44D1084007^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170901000000|||||||20170901000000|&Prostate, Radical Resection, Lymph Nodes, Regional Resection, PQRS Radical Prostatectomy|1770650145^^^^^^MD^^CMS^D^^^NPI||||||20170906000000|||F||||||C61^Malignant neoplasm of prostate^I10|1285672592&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\nThe patient's name is \"\" identified by requisition and specimen container label. Received in formalin in a container labeled with the patient's name and \"prostate pelvic lymph nodes\" is a radical prostatectomy specimen including attached seminal vesicles and vas deferens.   Weight: 37.2 g.   Size: 4 cm superior to inferior, 4.1 cm right to left and is up to 3.3 cm anterior to posterior.   Right seminal vesicle: Attached 1.5 x 1.2 x 0.6 cm.   Left seminal vesicle: Attached 2 x 1.3 x 0.5 cm.   Right vas deferens: Attached 2 x 0.6 x 0.5 cm.   Left vas deferens: Attached 2.2 x 0.6 x 0.5 cm.   Prostatic surface: Tan to red-brown granular around the bladder base.   Inking code: Right half green, left half blue, anterior midline orange, posterior midline black.   Sectioning: Apex and bladder base shaved off to be submitted. Remaining gland sectioned into 9 slices, numbered 1-9 sequentially from apex to base.   Cut surface: The cut surface is yellow-tan. Within the proximal to mid portion of the left lobe is a 1.5 x 1 x 0.9 cm circumscribed yellow nodule which is 0.3 cm to the inked capsule. In the right apical area of the inferior aspect of the lobe is a 1 x 1 x 0.8 cm circumscribed yellow-tan nodule. Included in the container is a 3.5 x 2.5 x 2 cm aggregate of fatty tissue. On section the tissue contains six 0.3 x 0.2 x 0.2 to 1.6 x 0.9 x 0.8 cm yellow-tan candidate nodes. Section code: Representative sections, including the entire prostate gland, are submitted as follows: Cassette summary:   1A, right apex   1B, left apex   1C, right bladder base   1D-1E, left bladder base   1F, right seminal vesicle and right vas deferens at margin   1G, left seminal vesicle and vas deferens at margin   1H, right level 1   1I-1J, right level 2   1K, right level 3   1L-1M, right level 4   1N-1O, right level 5   1P-1Q, right level 6   1R-1S, right level 7   1T-1V, right level 8   1W, right level 9   1X, left level 1   1Y-1Z, left level 2   1AA, left level 3   1AB-1AC, left level 4   1AD-1DE, left level 5   1AF-1AG, left level 6   1AH-1AI, left level 7   1AJ-1L, left level 8   1AM, left level 9   1AN, 3 candidate lymph nodes submitted whole   1AO-1AQ, 1 candidate lymph node each bisected Note: A gross photograph is submitted. (RH)\n\n\nPath report.site of origin\n\nProstate and pelvic lymph nodes\n\n\nPath report.final diagnosis\n\nProstate and pelvic lymph nodes (radical prostatectomy and pelvic lymph node dissection):   Prostatic adenocarcinoma, Gleason's pattern 3+4=7 (10% pattern 4, grade group     2).   Tumor is bilateral occupying 15% of the gland.   No extraprostatic extension identified.   The seminal vesicles are not involved.   Perineural invasion is seen.   No lymphovascular invasion identified.   All margins of resection are negative.   The remaining gland demonstrates high grade prostatic intraepithelial neoplasia.   Four lymph nodes free of metastasis (0/4).   Stage: pT2c pN0.  CANCER CHECKLIST: PROSTATE GLAND: Radical Prostatectomy 3.000.001.1000043 SPECIMEN  Procedure: Radical prostatectomy Prostate Size  Prostate Weight (g): 37.2grams  Prostate Size in Centimeters (cm): 4.1cm  Additional Dimension in Centimeters (cm): 4.0cm, 3.3cm TUMOR  Histologic Type: Acinar adenocarcinoma Histologic Grade  Gleason Pattern: Gleason pattern  Percentage of Pattern 4: 10%  Primary Gleason Pattern: Pattern 3  Secondary Gleason Pattern: Pattern 4  Total Gleason Score: 7  Grade Group: Grade group 2  Intraductal Carcinoma (IDC): Not identified Tumor Extent  Tumor Quantitation: Estimated percentage of prostate involved by tumor (specify %)  Estimated percentage of prostate involved by tumor (specify %): 15%  Extraprostatic Extension (EPE): Not identified  Urinary Bladder Neck Invasion: Not identified  Seminal Vesicle Invasion: Not identified Accessory Findings  Treatment Effect: No known presurgical therapy  Lymphovascular Invasion: Not Identified  Perineural Invasion: Not identified MARGINS  Margins: Uninvolved by invasive carcinoma LYMPH NODES  Number of Lymph Nodes Involved: None identified  Number of Lymph Nodes Examined: Specify number  Specify number: 4 PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition)  Primary Tumor (pT)#: pT2: Organ confined  Regional Lymph Nodes (pN): pN0: No positive regional nodes ADDITIONAL FINDINGS  Additional Pathologic Findings: High-grade prostatic intraepithelial neoplasia (PIN)\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Malignant neoplasm of prostate (C61)\n\n\n"
}